Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| FEDERAL MOGU | FDML | 8.32% |
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 6.93% |
| RADIANT LOGI | RLGT | 6.38% |
| NATUS MEDICA | BABY | 5.34% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Accenture plc ( ACN - Snapshot Report ) recently announced that it has clinched a 5-year service agreement with a financial service group, Nordea. Financial terms of the deal were not disclosed.
Per the contract terms, Accenture will develop advanced applications for smooth operational tasks involving risk management, treasury, human resources and procurement management. Also, the company will supervise the existing applications.
The scope of the agreement also requires Accenture to carry on the task of supporting Nordea’s Basel II compliance reporting system. This Basel II agreement was inked some time back and has now been extended.
Apart from this, Accenture’s service was selected by India’s Department of Electronics & Information Technology (DeitY). Per the contract, Accenture will develop a program whereby the government agency could compare details of technology providers and investors vying to develop a semiconductor facility in India. Through the help of the tailor-made system, the agency will be able to choose the best firm for handling the task.
Last week, District of Columbia opted for Accenture’s support to meet its health care reform deadlines.
Accenture’s comprehensive service offerings have made it one of the key IT service providers. A large product and service base has also lent the company a leading edge in the competitive market. Accenture has regularly won deals from all industrial sectors as well as the federal vertical.
Though Accenture’s deal prospects look bright, its large number of government deals (which carry low margins), stiff competition from IBM Corp. ( IBM - Analyst Report ) and significant European exposure may temper its growth going forward.
Currently, Accenture has a short-term Hold rating, denoted by the Zacks #3 Rank.
Read the full Snapshot Report on ACN
Read the full Analyst Report on IBM